News | October 21, 2010

Daniel S. Berman Receives Pioneer in Medicine Award

October 21, 2010 – Daniel S. Berman, M.D., an innovator of cardiac imaging technology for 30 years, has received the Pioneer in Medicine Award from Cedars-Sinai Medical Center, its highest honor.

Berman is recognized as one of the world’s pre-eminent clinical investigators in noninvasive cardiac imaging and one of the founding fathers of nuclear cardiology. He established the largest and most extensively studied patient database in the field of cardiac imaging, analyzing information from more than 60,000 patients. He and his team developed statistical models to predict the likelihood of severe cardiac events, and, in the process, they shaped the way cardiac imaging is practiced worldwide.

He also co-directed a program bringing together scientists, programmers and cardiologists to create software that enables computers to analyze 3-D images produced by advanced imaging technologies. The totally software – which takes subjective, human interpretation out of the equation and standardizes methodology – has been licensed and distributed to virtually all of the imaging technology manufacturers and is considered the standard in the field.

As a mentor and educator, Berman has had a major influence on the careers of countless medical students, cardiologists, radiologists, internists and technologists. He has held prominent leadership positions in virtually all of the national professional societies devoted to cardiovascular medicine and cardiovascular imaging. Throughout his career, he has served on a number of medical journal boards, and he has helped write guidelines for such organizations as the American College of Cardiology, the American Heart Association, the American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.

Berman also has published more than 350 articles in peer-reviewed journals, written 110 book chapters, and edited or co-edited five books.

Recruited 33 years ago to serve as director of nuclear cardiology, Berman quickly recognized the importance of “multimodality cardiac imaging” – the use of various technologies to establish an accurate picture of the heart and its function.

The Pioneer in Medicine Award was presented by Steven Galen, M.D., Vice Chief of Staff, and chair of the Pioneer in Medicine selection panel and John D. Friedman, M.D., chief of Outpatient Cardiac Imaging.

The award is presented to a member of Cedars-Sinai’s medical staff who meets numerous criteria and has made clinical and research contributions recognized at Cedars-Sinai and in the national or international medical communities. The recipient must have made a major contribution to the Medical Center, be or have been involved in research, have been published in national or international peer-reviewed journals, be a teacher and a positive role model, be an innovator or have changed the medical world around him or her, and have been a physician at the Medical Center during a major part of his or her career.

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Overlay Init